Survivor Julie Cohen discusses her experience with cevostamab, managing CRS side effects, and reaching MRD-negative status through a clinical trial.
Julie Cohen
Advertisement
Articles by Julie Cohen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
4
If I Have Cancer Again
5